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Propionibacterium acnes strains differentially regulate the fate of Th17 responses in the 
skin. 
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Abstract 
 Agak et al. demonstrate that different strains of Propionibacterium acnes, a bacterium 
colonizing the pilo-sebaceous unit in healthy skin and acne, have the ability to induce Th17 
cells secreting either IFNγ or IL-10 and exhibiting either pathogenic or protective properties, 
respectively. This work contributes to the growing evidence that the phenotype of Th17 cells 
is largely dependent on their microbiological environment. 
 
 
Bullet points 
 
• Different Propionibacterium acnes strains induce pathogenic or protective Th17 
responses. 
 
• IFNγ-producing Th17 are pathogenic whereas IL-10-producting Th17 are protective. 
 
• The use of IL-17 inhibitors may impact both pathogenic and protective Th17. 
  
3  
 
Acne is an inflammatory disorder of the pilosebaceous unit commonly occurring at 
puberty and affecting up to 85% of adolescents and young adults. Currently, acne is 
considered as a multifactorial disease involving factors such as excess sebum production, 
disturbed keratinization in the hair follicle, colonization of the pilosebaceous unit by the 
bacterium Propionibactarium acnes (P. acnes) and the release of pro-inflammatory 
molecules. However, although being a highly prevalent and extensively studied inflammatory 
skin disorder, the precise physiopathology of acne is still not completely understood. 
P. acnes is an anaerobic Gram-positive bacterium present in the human skin 
microbiota. This commensal accumulates preferentially in pilosebaceaous units in both acne 
patients and healthy individuals. P. acnes overgrowth in acne microcomedones is associated 
with inflammation of the pilosebaceous unit. However, the role of this bacterium in the 
pathogenesis of acne has long been debated and how it contributes to acne while being a 
major component of the normal skin flora remains unclear. Several reports demonstrated that 
P. acnes is able to induce strong inflammatory responses by inducing the release of pro-
inflammatory cytokines and chemokines in cells present in or in close proximity of the 
pilosebaceous unit. Keratinocytes respond to P. acnes exposure by releasing IL-6 and IL-8 
(CXCL8), IL-1α, TNF and GM-CSF (Graham et al., 2004), while P. acnes stimulates the 
secretion of IL-1β, TNF, IL-8 and IL-12 by myeloid cells (Kistowska et al., 2013, Qin et al., 
2014). Moreover, sebocytes are also responsive to P. acnes exposure by releasing IL-8 
(CXCL8), TNF (Nagy et al., 2006) and IL-1β (Li et al., 2014).  
Despite the ability of P. acnes to induce robust innate immune responses, cells 
infiltrating early acne lesions consist mainly of CD4+ T cells. IL-17A-secreting CD4+ T cells 
(Th17 cells) bridge innate and adaptive immunity and their important role in mediating host 
defense and controlling different microorganisms is well documented. Increasing evidence 
suggests that P. acnes is able to induce Th17 cells which may therefore contribute to 
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inflammation in acne. Our group and the group lead by Jenny Kim at UCLA provided 
experimental evidence in the past showing that the secretion of IL-17A by naïve CD4+ T cells 
can be induced by P. acnes (Agak et al., 2013, Kistowska et al., 2015). We could furthermore 
show that IL-17A+/IFN-³ + Th17 cells - initially called “Th1/Th17” cells and also referred to 
as “Th1-like” cells  - could be inhibited by the use of a blocking antibody to IL-1β (Kistowska 
et al., 2015), a cytokine that has emerged as a crucial factor driving Th17 polarization. More 
recently, P. acnes-stimulated sebocytes have been shown to promote the differentiation of 
naïve T cells into Th17 in a mechanism involving TGFβ, IL-6 and IL-1β (Mattii et al., 2017). 
In this issue, Agak et al. go one step further by showing that the nature and possibly the 
pathogenicity of P. acnes strains directly influence the cytokine profile of Th17 cells as well 
as their microbicidal properties (Agak et al., 2017). While P. acnes found in acne lesions 
induced IFNγ-secreting Th17 cells with no microbicidal activity, P. acnes found on healthy 
skin induced IL-10-secreting Th17 cells that were able to lyse P. acnes in vitro. In 2014, we 
could already show that P. acnes could induce both IL-17A+/IFNγ- and IL-17+/IFNγ+ T cells 
(Kistowska et al., 2015). However, since we only analyzed one strain of P. acnes in our study, 
the interesting discovery of Agak et al. revealing the ability of selected P. acnes strains to 
induce different Th17 cells with different cytokine secretion profiles and antimicrobial 
properties was missed. P. acnes can be classified into distinct phylotypes which are associated 
with healthy skin or acne. It is known since the 1980s that type I P. acnes is strongly 
associated with acne and it has been recently shown that strains of phylotypes IA-2, IB-1 and 
IC are also associated with acne, whereas phylotypes IB-3, II and III are associated with other 
tissue infections. Importantly, a very strong association has been reported between the 
phylotype II, ribotype 6 (II-RT6) subgroup and healthy skin, and furthermore phylotype III P. 
acnes isolates have been reported to be absent in acne lesions, but to compose approximately 
20% of healthy skin isolates (Fitz-Gibbon et al., 2013, McDowell et al., 2013). The reason(s) 
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why RT6 P. acnes is exclusively present in healthy skin remain(s), however, to be 
determined. Constitutive differences in microbiome composition between individuals due to 
factors including hormone level, sebum production and changes in the pilosebaceous unit, 
may also account for P. acnes strain composition and therefore likely drive its pathogenicity. 
However, whether the RT6 P. acnes phylotype is immunologically active in mediating a 
protective effect against acne remains to be investigated. The work of Agak et al. provides 
however an indication thereof by demonstrating that only non-pathogenic P. acnes isolates 
found on healthy skin induced IL-10-secreting Th17 cells that were able to lyse P. acnes in 
vitro and, therefore, possibly participate in bacterial clearance in vivo. 
While Th17 cells can be beneficial in clearing infection, excessive pro-inflammatory 
Th17 responses can be pathogenic. The findings of Agak et al. provide further evidence that 
Th17 cells are not always pathogenic. Indeed, Esplugues et al. previously demonstrated that 
excessive immune responses could be prevented by Th17 cells via IL-17-dependent 
upregulation of CCL20 in the gastro-intestinal tract (Esplugues et al., 2011). The  P. acnes 
phylotype specific protective Th17 responses described by Agak et al. in this issue thus likely 
involve the immuno-modulatory effect of IL-10 and the microbicidal properties of Th17 cells. 
The data of Agak et al. further suggest that in the skin, P. acnes plays a role in 
regulating the fate of Th17 to “Th17/Th1” differentiation programs, and the possible 
phenotypic plasticity in the late development of Th17 and Th1 cells. Th17 cells are known to 
display a high degree of plasticity driven by their environment (Muranski and Restifo, 2013). 
Th17 cells producing both IL-17 and IFNγ were first described in 2007 in patients with 
Crohn's disease and reported to result from a phenotypic shift of Th17 cells upon exposure to 
IL-12 (Annunziato et al., 2007). The microbial microenvironment is currently seen as an 
important factor in the development of Th17 or “Th17/Th1” responses, and fungi, not 
bacteria, specifically induce IL-12 secretion from antigen-presenting cells (APCs), resulting 
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in the phenotypic differentiation of fungus-specific Th17 cells towards the production of IL-
17 and IFN³ . Indeed, in 2012, Zielinsky et al. reported that Candida albicans could induce 
IL-17+/IFN-³ +/IL-10- Th17 cells in an IL-12-dependent manner whereas Staphylococcus 
aureus induced Th17 cells to produce IL-10 (Zielinski et al., 2012). Interestingly, IL-1β was 
shown to be essential for Candida albicans-specific Th17 differentiation, whereas IL-1β 
inhibition promoted IL-10 production. The work of Agak et al. goes beyond the interesting 
field of distinct Th17 phenotypic properties regulated by bacteria and fungi demonstrating 
now that different strains (phylotypes) of a same bacteria may regulate the nature of Th17 
responses. Thus, there is increasing evidence that such dichotomous Th17 responses largely 
depend on the local context and composition of the microbiome. The nature of the contextual 
commensal and/or pathogen and, amongst others, its ability to induce IL-12 and IL-1β or not 
may be key drivers of pathogenic or non-pathogenic Th17 responses (Figure 1). In such a 
context, the use of IL-1β inhibitors may rather favor IL-10-producing Th17 cells, described to 
be protective in certain situations (McGeachy et al., 2007), rather than fully inhibiting Th17 
differentiation. Moreover, based on the report of Agak et al. one could hypothesize that the 
use of IL-17A inhibitors alone may also impair the protective function of Th17 cells and 
therefore not be specific enough to selectively treat the excessive inflammation characteristic 
of acne. 
As reported in this issue, the findings from Agak et al. demonstrating P. acnes strain-
dependent effects on the differentiation of Th17 subsets resulting in contrasting biological 
properties (pathogenic vs. protective) highlight the complexity of cutaneous microbiome/host 
interactions in skin health and disease.  
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